Protagonist Therapeutics, Inc. (PTGX)
PTGX price $138.08 +0.09 +0.07%
- Ticker
- PTGX
- Price
- $138.08
- Change
- +0.09 +0.07%
- Market cap
- $8.93B
- P/E
- 113.28
- Forward P/E
- 30.03
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's pipeline features rusfertide (PTG-300), an injectable hepcidin mimetic currently undergoing Phase II clinical trials for the management of…